The enzyme phenylalanine hydroxylase is almost exclusively limited to the liver although some activity may be found in the kidney and the intestinal mucosa. Determination of this enzyme activity ...
EurekAlert!: The American College of Medical Genetics and Genomics (ACMG) releases highly anticipated evidence-based clinical guideline for phenylalanine hydroxylase deficiency
The American College of Medical Genetics and Genomics has just published its highly anticipated Evidence-Based Clinical Guideline (EBG): “Phenylalanine Hydroxylase (PAH) Deficiency Diagnosis and ...
The American College of Medical Genetics and Genomics (ACMG) releases highly anticipated evidence-based clinical guideline for phenylalanine hydroxylase deficiency
Phenylalanine hydroxylase deficiency is an autosomal recessive disorder that results in intolerance to the dietary intake of the essential amino acid phenylalanine. It occurs in approximately 1:15,000 ...
Hyperphenylalaninemia is a common inherited metabolic disease that is due to phenylalanine hydroxylase deficiency, and at least half the affected patients have mild clinical phenotypes. Treatment with ...
Nature: Three Polymorphisms but No Disease-Causing Mutations in the Proximal Part of the Promoter of the Phenylalanine Hydroxylase Gene
In phenylketonuria (PKU) and nonketonuric hyperphenylalaninemia (HPA), an inherited (autosomal recessive) deficiency of the liver-specific enzyme phenylalanine hydroxylase (PAH; phenylalanine ...
Three Polymorphisms but No Disease-Causing Mutations in the Proximal Part of the Promoter of the Phenylalanine Hydroxylase Gene
Overview Phenylketonuria (fen-ul-key-toe-NU-ree-uh), also called PKU, is a rare inherited disorder that causes an amino acid called phenylalanine to build up in the body. PKU is caused by a change in the phenylalanine hydroxylase (PAH) gene. This gene helps create the enzyme needed to break down phenylalanine.